Saturday, July 12, 2014 2:24:00 PM
http://www.chicagobusiness.com/article/20140711/NEWS03/140719950/ventas-officials-inappropriate-relationship-doesnt-shake-its-stock
The market's reaction to Ventas Inc.'s news this week that it severed ties with its auditing firm seems to be a resounding “meh.”
The Chicago-based real estate investment trust on July 9, via statement and regulatory filing, said it would no longer be a client of Ernst & Young LLP after the New York-based accounting giant notified it of an “inappropriate personal relationship” between an Ernst & Young senior audit partner and Ventas' now-former chief accounting officer and controller Robert Brehl.
In light of the relationship, Ernst & Young said it could no longer be considered an independent auditor. Now Ventas' new auditing firm, KPMG LLP, must re-audit its results from 2012 and 2013, though the company says financial statements from the period accurately reflect the state of the enterprise. Ventas also says that Mr. Brehl's separation was “not due to any disagreement . . . regarding its financial reporting or accounting operations, policies or practices.”
The reported results, the company said in a statement, “may continue to be relied upon.”
The market apparently agrees. On Thursday, the day after news of the dismissal of Ernst & Young — and its unusual cause — went public, Ventas' stock inched up less than a half-percent, and as of this afternoon, it was trading at $64.10, about 0.3 percent higher than it was at the beginning of the week.
THE LONG VIEW
Fitch Ratings Inc. today reaffirmed its BBB+ rating on Ventas' debt and said it “does not expect the announcement to result in a change in the company's long-term credit profile.”
In the short term, the ratings agency noted, the news may present some complications because Ventas cannot issue stock while KMPG is re-auditing the company's books. Ventas in June announced the acquisition of American Realty Capital Healthcare REIT for $2.6 billion in cash and 26.9 million shares of stock. The deal is set to close in the fourth quarter.
Fitch, however, said it expects the new audits to be done “well in advance” of the acquisition.
A REIT, Ventas owns and operates a portfolio of about 1,500 health care properties in 47 states, Canada and the United Kingdom. It booked $2.81 billion in revenue in 2013.
A spokeswoman for Ventas declined to comment on the matter beyond the company's press release and its 8-K filing with the Securities and Exchange Commission.
'PROMPTLY TERMINATED'
A spokesman for Ernst & Young in New York said the audit partner involved in the relationship with Mr. Brehl was no longer with the company.
"This partner's actions were a flagrant violation of our firm's code of conduct and professional standards,” John La Place, assistant director of brand, marketing and communications, wrote in an email. “Upon our learning of this matter, the partner was promptly terminated.”
The partner could not be reached for comment. In its SEC filing, the firm said the official was the lead audit partner on the 2014 audit and quarterly review and worked on the 2012 and 2013 audits.
Mr. Brehl also could not be reached for comment. As of March, he owned about 21,000 shares of the company, according to Bloomberg LP.
"Then there was a woman, a lion of a woman."
Recent VTR News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 01:53:56 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/18/2024 09:24:13 PM
- Ventas Declares Third Quarter 2024 Dividend of $0.45 Per Common Share • Business Wire • 09/17/2024 08:39:00 PM
- Ventas Reaches Agreements with Kindred and ScionHealth • Business Wire • 09/16/2024 03:09:00 PM
- Ventas Reaches Agreements with Kindred and ScionHealth • Business Wire • 09/16/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 09:39:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 09:38:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 09:37:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/10/2024 08:43:21 PM
- Ventas Releases 2023-2024 Corporate Sustainability Report • Business Wire • 09/09/2024 11:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 09:13:23 PM
- Ventas to Participate in Investor Meetings at BofA Securities 2024 Global Real Estate Conference • Business Wire • 09/09/2024 09:06:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/09/2024 08:46:00 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 09/06/2024 09:16:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 09:07:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2024 08:36:44 PM
- Ventas Announces Pricing of Senior Notes Offering • Business Wire • 09/05/2024 09:07:00 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 09/05/2024 09:03:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2024 08:06:26 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/05/2024 01:09:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/04/2024 08:25:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 09:42:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 09:40:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/27/2024 09:04:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/27/2024 08:49:42 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM